Addition of Multimodal Therapy to Standard Management of Steady State Sickle Cell Disease
Addition of Multimodal Therapy to Standard Management of Steady State Sickle Cell Disease
About this item
Full title
Author / Creator
Okpala, Iheanyi , Ezenwosu, Osita , Ikefuna, Anthony , Duru, Augustine , Chukwu, Barth , Madu, Anazoeze , Nwagha, Theresa , Ocheni, Sunday , Ibegbulam, Obike , Emodi, Ifeoma , Anike, Uche , Nonyelu, Charles , Anigbo, Chukwudi , Agu, Kingsley , Ajuba, Ifeoma , Chukwura, Awele , Ugwu, Ogechukwu , Ololo, Uche , Ikuta, T. and Fiedler, W.
Publisher
Egypt: Hindawi Publishing Corporation
Journal title
Language
English
Formats
Publication information
Publisher
Egypt: Hindawi Publishing Corporation
Subjects
More information
Scope and Contents
Contents
Most people on folic acid to boost erythropoiesis and prophylactic antimicrobials, the standard management of steady state sickle cell disease (SCD), have unacceptable numbers of crises. The objective of this study was to evaluate the effects of adding multimodal therapy with potassium thiocyanate and omega-3 fatty acids to the standard management...
Alternative Titles
Full title
Addition of Multimodal Therapy to Standard Management of Steady State Sickle Cell Disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3872154
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3872154
Other Identifiers
ISSN
2090-441X,2090-4428
E-ISSN
2090-4428
DOI
10.1155/2013/236374
